Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 comparison of rivaroxaban vs acetylsalicylic acid
jRCT2080223885Phase 3Completed
- Start
- Apr 2018
- Modality
- Small Molecules
01
Overview
Phase 3, randomised trial of rivaroxaban in thromboembolism and cardiac morbidity (2 arms). Started Apr 2018; status: completed.
02
Drugs
rivaroxaban
03
Conditions
thromboembolismcardiac morbidity
Beyond the preview
Go deeper on jRCT2080223885.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080223885.